Your browser doesn't support javascript.
loading
Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis.
Gramlich, Oliver W; Brown, Alexander J; Godwin, Cheyanne R; Chimenti, Michael S; Boland, Lauren K; Ankrum, James A; Kardon, Randy H.
Affiliation
  • Gramlich OW; Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, USA.
  • Brown AJ; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
  • Godwin CR; Department of Biomedical Research, National Jewish Health, Denver, CO, USA.
  • Chimenti MS; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Boland LK; Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, USA.
  • Ankrum JA; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
  • Kardon RH; Iowa Institute of Human Genetics, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA.
Transl Vis Sci Technol ; 9(8): 16, 2020 07.
Article in En | MEDLINE | ID: mdl-32855863

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Multiple Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Transl Vis Sci Technol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Multiple Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Transl Vis Sci Technol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos